Back

Treating HPV infections

October 16, 2025

Improving women's healthcare

Every two minutes, a woman dies from cervical cancer, caused by an untreated HPV infection. To help change that, Produvation and Spark have joined forces as Veya Medical to develop a hyperthermic therapy that treats HPV infections early and helps prevent cervical cancer from developing.

News item image

We have successfully completed the first stage: a feasibility study. Supported by government funding, we confirmed that our technology works and explored how it can be integrated into existing healthcare systems. Because medical innovation only makes a real impact when it fits within current care structures. We are receiving overwhelmingly enthusiastic support from both patients and gynecologists, recognizing the need for intervention solutions in HPV infections.

Now, we are looking for investors who want to join this meaningful mission to improve women’s health worldwide. The market potential is huge, and together we can make a real impact. Interested or looking for more information? Contact Remi Veenman

Spark’s director Medical Remi: “We believe in better healthcare. And right now, women’s health is lagging behind. By working closely with doctors and patient associations, we can create a product that saves women’s lives around the world.”

Get in touch

Name

Email

Message

Send

Thank you.

Your submission has been received. We will get back to you as soon as possible.
Oops! Something went wrong while submitting the form. Please try again.